Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale

Abstract Item response theory (IRT) has been recently adopted to successfully characterize the progression of Parkinson's disease using serial Unified Parkinson's Disease Rating Scale (UPDRS) measurements. However, it has yet to be applied in predicting the longitudinal changes of levodopa...

Full description

Bibliographic Details
Main Authors: Dongwoo Chae, Su Jin Chung, Phil Hyu Lee, Kyungsoo Park
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:CPT: Pharmacometrics & Systems Pharmacology
Online Access:https://doi.org/10.1002/psp4.12632
id doaj-02c3e101d87447ec97ad46ffd1fbfc07
record_format Article
spelling doaj-02c3e101d87447ec97ad46ffd1fbfc072021-06-18T20:44:13ZengWileyCPT: Pharmacometrics & Systems Pharmacology2163-83062021-06-0110661162110.1002/psp4.12632Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating ScaleDongwoo Chae0Su Jin Chung1Phil Hyu Lee2Kyungsoo Park3Division of Pharmacometrics Department of Pharmacology Yonsei University College of Medicine Seoul South KoreaDepartment of Neurology Myongji Hospital Hanyang University College of Medicine Goyang South KoreaDepartment of Neurology Yonsei University College of Medicine Seoul South KoreaDivision of Pharmacometrics Department of Pharmacology Yonsei University College of Medicine Seoul South KoreaAbstract Item response theory (IRT) has been recently adopted to successfully characterize the progression of Parkinson's disease using serial Unified Parkinson's Disease Rating Scale (UPDRS) measurements. However, it has yet to be applied in predicting the longitudinal changes of levodopa dose requirements in the real‐world setting. Here we use IRT to extract two latent variables that represent tremor and non‐tremor‐related symptoms from baseline assessments of UPDRS Part III scores. We show that relative magnitudes of the two latent variables are strong predictors of the progressive increase of levodopa equivalent dose (LED). Retrospectively collected item‐level UPDRS Part III scores and longitudinal records of prescribed medication doses of 128 patients with de novo PD extracted from the electronic medical records were used for model building. Supplementary analysis based on a subset of 36 patients with at least three serial assessments of UPDRS Part III scores suggested that the two latent variables progress at significantly different rates. A web application was developed to facilitate the use of our model in making individualized predictions of future LED and disease progression.https://doi.org/10.1002/psp4.12632
collection DOAJ
language English
format Article
sources DOAJ
author Dongwoo Chae
Su Jin Chung
Phil Hyu Lee
Kyungsoo Park
spellingShingle Dongwoo Chae
Su Jin Chung
Phil Hyu Lee
Kyungsoo Park
Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
CPT: Pharmacometrics & Systems Pharmacology
author_facet Dongwoo Chae
Su Jin Chung
Phil Hyu Lee
Kyungsoo Park
author_sort Dongwoo Chae
title Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
title_short Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
title_full Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
title_fullStr Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
title_full_unstemmed Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
title_sort predicting the longitudinal changes of levodopa dose requirements in parkinson’s disease using item response theory assessment of real‐world unified parkinson's disease rating scale
publisher Wiley
series CPT: Pharmacometrics & Systems Pharmacology
issn 2163-8306
publishDate 2021-06-01
description Abstract Item response theory (IRT) has been recently adopted to successfully characterize the progression of Parkinson's disease using serial Unified Parkinson's Disease Rating Scale (UPDRS) measurements. However, it has yet to be applied in predicting the longitudinal changes of levodopa dose requirements in the real‐world setting. Here we use IRT to extract two latent variables that represent tremor and non‐tremor‐related symptoms from baseline assessments of UPDRS Part III scores. We show that relative magnitudes of the two latent variables are strong predictors of the progressive increase of levodopa equivalent dose (LED). Retrospectively collected item‐level UPDRS Part III scores and longitudinal records of prescribed medication doses of 128 patients with de novo PD extracted from the electronic medical records were used for model building. Supplementary analysis based on a subset of 36 patients with at least three serial assessments of UPDRS Part III scores suggested that the two latent variables progress at significantly different rates. A web application was developed to facilitate the use of our model in making individualized predictions of future LED and disease progression.
url https://doi.org/10.1002/psp4.12632
work_keys_str_mv AT dongwoochae predictingthelongitudinalchangesoflevodopadoserequirementsinparkinsonsdiseaseusingitemresponsetheoryassessmentofrealworldunifiedparkinsonsdiseaseratingscale
AT sujinchung predictingthelongitudinalchangesoflevodopadoserequirementsinparkinsonsdiseaseusingitemresponsetheoryassessmentofrealworldunifiedparkinsonsdiseaseratingscale
AT philhyulee predictingthelongitudinalchangesoflevodopadoserequirementsinparkinsonsdiseaseusingitemresponsetheoryassessmentofrealworldunifiedparkinsonsdiseaseratingscale
AT kyungsoopark predictingthelongitudinalchangesoflevodopadoserequirementsinparkinsonsdiseaseusingitemresponsetheoryassessmentofrealworldunifiedparkinsonsdiseaseratingscale
_version_ 1721372699202158592